본문 바로가기
KERD
논문KCI 등재

漆皮 추출물의 담도암 세포주 SNU-1079와 SNU-1196에 대한 항암효과

Study on Anti-Cancer Effects of Rhus Verniciflua Stokes Extracted with Sterile Distilled Water on Two Cholangiocarcinoma Cell Lines, SNU-1079 and SNU-1196

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: This study was performed to investigate the anti-cancer effects of Rhus verniciflua Stokes (RVS) extracted with sterile distilled water on cholangiocarcinoma cell lines. Materials and Methods: Two cholangiocarcinoma cell lines, SNU-1079 and SNU-1196, were used in this study. Cells were treated with different concentrations of RVS for 24, 48, and 72 hours. Cell count, viability, apoptosis, and mRNA expression of Bax, Bcl-2, Mcl-1, survivin, caspase-3, and cyclin D1 and P21 were determined with an automatic cell counter (ADAM-MC), MTT assay, apoptosis assay (Annexin-V/PI staining), and RT-PCR. Results: All cells treated with RVS showed decreased cell counts in a dose-dependent manner. RVS inhibited proliferation of SNU-1196 in a dose-dependent manner, but SNU-1079 proliferation was inhibited in the long-time culture group in a dose-dependent manner. The proportion of early and late-stage apoptotic cells was increased by RVS in a dose-dependent manner in SNU-1196. In contrast, it was increased significantly in SNU-1079 treated with high-dose RVS. After treatment with RVS, the mRNA expression of Bcl-2 was decreased while Bax was increased in SNU-1079. Cyclin D1 mRNA levels were decreased in SNU-1196 in a dose-dependent manner. P21 expression was increased in all cells after the treatment with RVS. Conclusions: RVS appears to have potential as a therapeutic agent for cholangiocarcinoma.

Abstract

Objectives: This study was performed to investigate the anti-cancer effects of Rhus verniciflua Stokes (RVS) extracted with sterile distilled water on cholangiocarcinoma cell lines. Materials and Methods: Two cholangiocarcinoma cell lines, SNU-1079 and SNU-1196, were used in this study. Cells were treated with different concentrations of RVS for 24, 48, and 72 hours. Cell count, viability, apoptosis, and mRNA expression of Bax, Bcl-2, Mcl-1, survivin, caspase-3, and cyclin D1 and P21 were determined with an automatic cell counter (ADAM-MC), MTT assay, apoptosis assay (Annexin-V/PI staining), and RT-PCR. Results: All cells treated with RVS showed decreased cell counts in a dose-dependent manner. RVS inhibited proliferation of SNU-1196 in a dose-dependent manner, but SNU-1079 proliferation was inhibited in the long-time culture group in a dose-dependent manner. The proportion of early and late-stage apoptotic cells was increased by RVS in a dose-dependent manner in SNU-1196. In contrast, it was increased significantly in SNU-1079 treated with high-dose RVS. After treatment with RVS, the mRNA expression of Bcl-2 was decreased while Bax was increased in SNU-1079. Cyclin D1 mRNA levels were decreased in SNU-1196 in a dose-dependent manner. P21 expression was increased in all cells after the treatment with RVS. Conclusions: RVS appears to have potential as a therapeutic agent for cholangiocarcinoma.

참고문헌 (25)

  1. DeOliveira ML, "Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution", Ann Surg, 245, pp.755~762 (2007)
  2. "중앙행정기관-보건복지부-통계 발간물-주제별-질병/건강-국가암 등록사업 연례보고서(2010년 암등록통계)" (2014)[URL]
  3. Blechacz BG, "Sleisenger and Fordtran’s gastrointestinal and liver disease, Volume 1. 9th ed", pp.1171~1176 (2010), Saunders
  4. Aljiffry M, "Advances in diagnosis, treatment and palliation of cholangiocarcinoma 1990-2009", World Journal of Gastroenterology, 15, pp.4240~4262 (2009)
  5. Son YO, "Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines", Toxicology Letters, 155(1), pp.115~125 (2005)
  6. Jang HS, "Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells", Biochimica et Biophysica Acta, 1726(3), pp.309~316 (2005)
  7. Samoszuk M, "The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts", BMC Complementary and Alternative Medicine, 5(5) (2005)
  8. Lee JC, "Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells", Food and Chemical Toxicology, 42(9), pp.1383~1388 (2004)
  9. 지형준, "대한약전 및 대한약전외 한약규격주해" (1998), 한국메디칼인덱스사
  10. 송창훈, "원위부 담도암 환자 증례 보고", 대한한방내과학회지, 27(3), pp.771~776 (2006), 대한한방내과학회
  11. 이경욱, "茵蔯의 에탄올 추출물이 담도암 세포주 SNU-1196의 apoptosis에 미치는 효과에 관한 연구", 대한한방내과학회지, 33(4), pp.587~598 (2012), 대한한방내과학회
  12. 박진규, "담관암세포주에서 地楡 에탄올 추출물의 항암 효과", 대한한방내과학회지, 33(4), pp.465~475 (2012), 대한한방내과학회
  13. Lee JO, "Rhus verniciflua Extract Modulates Survival of MCF-7 Breast Cancer Cells through the Modulation of AMPK-Pathway", Biological & Pharmaceutical Bulletin, 37(5), pp.794~801 (2014)
  14. Lee JC, "Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells", Food and Chemical Toxicology, 42, pp.1383~1388 (2004)
  15. Junttila MR, "Influence of tumour micro-environment heterogeneity on therapeutic response", Nature, 501, pp.346~354 (2013)
  16. Sirica AE, "The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma", Nature Reviews Gastroenterology & Hepatology, 9, pp.44~54 (2012)
  17. Kalluri R, "Fibroblasts in cancer", Nature Reviews Cancer, 6, pp.392~401 (2006)
  18. Nguyen M, "Human endothelial gelatinases and angiogenesis", International Journal of Biochemistry and Cell Biology, 33(10), pp.960~970 (2001)
  19. Moon G, "Effect of allergen removed Rhus verniciflua extract on inhibition of tumor metastasis", Journal of Korean Traditional Oncology, 15(1), pp.47~61 (2010)
  20. 김준식, "식물 추출물의 혈관신생 억제 효능 검색", 생약학회지, 37(4), pp.253~257 (2006), 한국생약학회
  21. 정성훈, "담관암세포주에서 내인성 peroxisome proliferator-activated receptor gamma 배위자인 15-deoxy-delta(12,14)-prostaglandin J2의 항암 효과", 대한내과학회지, 78(1), pp.75~86 (2010), 대한내과학회
  22. Oltvai ZN, "Bcl-2heterodimerizes in vivo with a conserved homolog, Bax that accelerates programmed cell death", Cell press, 74(4), pp.609~619 (1993)
  23. Tamm I, "IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas(CD95), Bax, caspases, and anticancer drugs", Cancer Research, 58(23), pp.5315~5320 (1998)
  24. Hardwick JM, "Cyclin' on the viral path to destruction", Nature Cell Biology, 2(11), pp.E203~E204 (2000)
  25. Kufe DW, "Cancer medicine 6" (2003), BC Decker

관련 논문AI추천

이 간행물의 다른 논문 (7건)